Clinical Trials Browser

Phase 2 × Neuroblastoma × Drug Therapy × Clear all

NCT06933394 2025-04-18

Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma

Phase 2 Recruiting

Neuroblastoma

NCT00389766 2013-07-10

High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma

Phase 2 Withdrawn

Neuroblastoma